Myrna F. Watanabe | Apr 1, 2007 | 4 min read
By Myrna F. WatanabeSUCCESS IN TWO CAREERSCultivating an eye for targets. DANI BOLOGNESI JASON VARNEY | varneyphoto.com By all accounts, Dani Bolognesi has been tremendously successful. His Duke University laboratory did the early work on identifying anti-HIV activity in what would become AZT (zidovudine), the first drug developed against the disease. In March 2003, the Food and Drug Administration approved Fuzeon, an HIV fusion-inhibitor drug that cam